Cargando…
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults
BACKGROUND: Nursing home residents, a frail and old population group, respond poorly to primary mRNA COVID-19 vaccination. A third dose has been shown to boost protection against severe disease and death in this immunosenescent population, but limited data is available on the immune responses it ind...
Autores principales: | Pannus, Pieter, Depickère, Stéphanie, Kemlin, Delphine, Georges, Daphnée, Houben, Sarah, Olislagers, Véronique, Waegemans, Alexandra, De Craeye, Stéphane, Francotte, Antoine, Chaumont, Félicie, Van Oostveldt, Celien, Heyndrickx, Leo, Michiels, Johan, Willems, Elisabeth, Dhondt, Emilie, Krauchuk, Marharyta, Schmickler, Marie-Noëlle, Verbrugghe, Mathieu, Van Loon, Nele, Dierick, Katelijne, Matagne, André, Desombere, Isabelle, Ariën, Kevin K., Marchant, Arnaud, Goossens, Maria E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040352/ https://www.ncbi.nlm.nih.gov/pubmed/36997386 http://dx.doi.org/10.1016/j.vaccine.2023.03.047 |
Ejemplares similares
-
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial
por: Pannus, Pieter, et al.
Publicado: (2022) -
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients
por: Kemlin, Delphine, et al.
Publicado: (2023) -
The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.
por: Goossens, Maria E., et al.
Publicado: (2021) -
Younger Children Develop Higher Effector Antibody Responses to SARS-CoV-2 Infection
por: Tomasi, Lisa, et al.
Publicado: (2022) -
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients
por: Baron, Frédéric, et al.
Publicado: (2022)